Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria

American Journal of Transplantation

Volumn 7, Issue 4, 2007, Pages 972-981

  Cillo, U ^a   Vitale, A ^b   Grigoletto, F ^c   Gringeri, E ^a   D'Amico, F ^a   Valmasoni, M ^a   Brolese, A ^a   Zanus, G ^a   Srsen, N ^a   Carraro, A ^a   Burra, P ^c   Farinati, F ^c   Angeli, P ^c   D'Amico, D F ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Aggressive therapy; Hepatocellular carcinoma; Liver transplantation; Tumor biology

Indexed keywords

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HUMAN; LIVER CELL CARCINOMA; LIVER NODULE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT INDICATION;

ADULT; AGED; ALGORITHMS; BIOPSY; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; ITALY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PROBABILITY; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WAITING LISTS;

EID: 33947586730     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01719.x     Document Type: Article

References (33)

1. Befeler AS, Hayashi PH, Di Bsceglie AM. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2005; 128: 1752-1764.
2. Bismuth H, Chiche L, Adam R et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145-151.
3. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
4. Llovet JM, Bruix J, Fuster J et al. Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power. Hepatology 1998; 27: 1572-1577.
5. Jonas S, Bechstein WO, Steinmuller T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086.
6. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: A registry report of the impact of the tumor characteristics on outcome. Ann Surg 1998; 228: 479-490.
7. Marsh JW, Dvorichik I, Subotin M et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study. Hepatology 1997; 26: 444-450.
8. Iwatsuki S, Dvorchik I, Marsh JW et al. Liver transplantation for hepatocellular carcinoma: A proposal of a prognostic scoring system. J Am Coll Surg 2000; 191: 389-394.
9. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000; 88: 538-543.
10. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999; 30: 1434-1440.
11. Yao FY, Bass NM, Nikolai B et al. Liver transplantation for hepatocellular carcinoma. Analysis of survival according to the intention-to-treat principle, and drop-out from the waiting list. Liver Transpl 2002; 8: 873-883.
12. Yao FY, Bass NM, Nikolai B et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy. Liver Transpl 2003; 9: 684-692.
13. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: Lessons from the first year under the model of end-stage liver disease (MELD) organ allocation policy. Liver Transpl 2004; 10: 621-630.
14. Graziadei IW, Sandmueller H, Waldenberger P et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9: 557-563.
15. Lu DSK, Yu NC, Raman SS et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005; 41: 1130-1137.
16. Belghiti J, Cortes A, Abdalla EK et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003; 238: 885-892; discussion 892-893.
17. Yao FY, Kinkhabwala M, La Berge JM et al. The impact of preoperative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transpl 2005; 5: 795-804.
18. Huo TI, Wu JC, Lin HC et al. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy. Liver Transpl 2004; 10: 1507-1513.
19. Yao FY, Hirose R, LaBerge JM et al. A prospective study on down-staging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005; 11: 1505-1514.
20. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
21. Yao FY, Ferrel L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403.
22. Cillo U, Vitale A, Bassanello M et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004; 239: 150-159.
23. Vitale A, Brolese A, Zanus G et al. Multimodal therapy before liver transplantation for hepatocellular carcinoma. Hepatol Res 2005; 31: 112-115.
24. Bassanello M, Vitale A, Ciarleglio FA et al. Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: Impact on survival or HCV recurrence timing. Transpl Proc 2003; 35: 2991-2994.
25. Cillo U, Bassanello M, Vitale A et al. The critical issue of hepatocellular carcinoma prognostic classification: Which is the best tool available? J Hepatol 2004; 40: 124-131.
26. Cillo U, Vitale A, Grigoletto F et al. Prospective validation of the Barcelona clinic liver cancer staging system. J Hepatol 2006; 44: 723-731.
27. Edmonson H, Steiner P. Primary carcinoma of the liver: A study of 100 cases among 48900 necropsies. Cancer 1954; 1: 462-503
28. Roayaie S, Frischer JS, Emre SH et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235: 533-539.
29. Goodman J, Glasgow SC, Schnitzler M et al. Liver transplantation for hepatocellular carcinoma. Expanding special priority to include stage III disease. Arch Surg 2005; 140: 459-464.
30. Roayaie S, Schwartz JD, Sung MW et al. Recurrence of Hepatocellular Carcinoma after liver transplant: Patterns and prognosis. Liver Transpl 2004; 10: 534-540.
31. Pawlik TM, Delman KA, Vauthey JN et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005; 11: 1086-1092.
32. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy. Gastroenterology 2004; 127(Suppl 1): S261-S267.
33. Freeman RB, Edwards EB, Harper AM. Waiting list removal rates among patients with chronic and malignant liver disease. Am J Transpl 2006; 6: 1416-1421.